Concept
A desired product direction. No performance statement is publishable.
Tool 03 / Claim Evidence Ladder
The strongest category language is not the loudest. It names the property, the method, the sample, the result, the wash state, the scope, and the limitation—then freezes the construction that produced it.
A desired product direction. No performance statement is publishable.
A component document. Identify its scope; do not upgrade it to finished-product evidence.
A named laminate or material was tested under stated conditions.
The complete construction was tested at its likely failure paths.
Relevant results were repeated after the agreed care or commercial-laundry profile.
Claim wording is tied to the exact BOM, report, market, limitations, and change triggers.
Claim decoder
These cards define development requirements. They do not state that any named ProtectMySleep product has achieved the described performance.
What blocks liquid, where, at what pressure, and after how many washes?
E0 · Concept
Pending — not publishable
AATCC TM127 or applicable ASTM/ISO material method + finished-product containment protocol.
Test the laminate and the complete article at the center, binding, seams, corners, and closure in as-received and specified wash-aged states.
A membrane datasheet, a face-fabric story, or one flat swatch result.
A lab result does not guarantee containment at every seam, corner, care condition, or field-use event.
Only after review: “Tested for [defined liquid property] on [identified scope] using [method/protocol] in [sample and wash state], subject to [limits].”
Do you mean air flow, water-vapor transfer, liquid moisture management, or a sleep-temperature result?
E0 · Concept
Pending — not publishable
ASTM D737 for air permeability; AATCC TM204 or ASTM E96 for water-vapor transmission.
Name the property, method, units, conditions, orientation, complete laminate, and wash state.
Fiber identity, marketing adjectives, or WVTR presented as air flow.
Air-permeability or water-vapor data does not guarantee cooler sleep, comfort, or a clinical outcome.
Only after review: state the measured property, method, unit, conditions, laminate orientation, and wash state—do not collapse it into an undefined “breathable” claim.
Which particle, protein, or organism passage is being evaluated—and is the construction within method scope?
E0 · Concept
Pending — not publishable
ISO 21326 only where its material and construction scope applies, plus separate seam and closure assessment.
Identify the exact challenge, material or finished-product scope, result, limitations, and change-control triggers.
Pore size alone, ISO 4333 protein-reduction data, or language implying treatment of allergy or asthma.
A penetration or protein-reduction result does not prove prevention, treatment, or relief of allergy or asthma.
Only after review: “Tested for [defined challenge] penetration under [method] on [material or finished-product scope], with [limitations].”
Does the textile reduce a named surface protein under the method—not block its passage or change a human allergic response?
E0 · Concept
Pending — not publishable
ISO 4333:2022 for reduction activity of specified proteins on the surface of textile products.
Name the protein, textile scope, method edition, ELISA result, control, treatment, sample and wash state, and any permitted article wording.
Using a protein-reduction result as allergen-penetration evidence, a particle-barrier result, or a human-allergy claim.
ISO 4333 does not evaluate barrier passage and does not evaluate allergic reaction in human beings.
Only after review: state the named protein and measured surface-reduction activity under ISO 4333:2022, without converting it into barrier, relief, treatment, or prevention language.
Can the complete encasement limit ingress and egress after washing, abrasion, installation, and zipper cycling?
E0 · Concept
Pending — not publishable
Independent biological challenge + ASTM D2061-selected zipper tests + installation and wash aging + product-specific U.S. FIFRA device determination where sold with pesticidal intent.
Challenge fabric, seams, zipper chain, end stop/garage, and any penetration path in both directions. Review claims, intended use, design, function, production establishment, label directions, and state requirements before U.S. release.
A zipper, EPA general guidance, or a fabric-only test.
An encasement result does not prove room treatment, prevention of introduction, or elimination of an infestation; it is one element of integrated pest management.
Only after review: “Complete encasement tested for [ingress/egress] under [biological protocol] in [sample state], including seams and zipper terminal.”
Is the treatment protecting the article itself, or implying protection of people and public health?
E0 · Concept
Pending — not publishable
AATCC TM100/TM147 where appropriate + U.S. FIFRA treated-article assessment and wash durability.
Confirm the active treatment, registered use, permitted wording, article-protection limitation, and evidence after laundering.
A bacteria-reduction number used to imply disease prevention, cleaner air, or health protection.
Article-protection evidence does not establish protection of users, public-health benefit, disease prevention, or infection control.
Only after legal review: limit wording to protection of the treated article and the exact registered use; include the required article-protection limitation.
Is every relevant finish, membrane, adhesive, print, thread, and closure controlled?
E0 · Concept
Pending — not publishable
Supplier declarations + California AB 1817 certificate + risk-based total-organic-fluorine screening.
Document the full BOM and retain signed, current, product-specific evidence.
A narrow PFOA-free statement or an absolute zero/PFAS-free claim without an analytical basis.
A supplier declaration does not establish analytical zero, cover an uncontrolled BOM change, or replace jurisdiction-specific compliance review.
Only after review: “No intentionally added PFAS based on product-specific supplier certification for BOM [revision/date]”; do not convert this into an absolute nondetect claim.
Product Evidence Record
A test report is useful only when it is connected to the product revision, claim wording, sample state, market, and limitation it actually supports.
Product ID + BOM revision
Claim ID + exact wording
Market + legal classification
Method + version
Laboratory + accreditation scope
Report ID + test date
Sample lot + preconditioning
Wash protocol + cycles
Result + unit + acceptance criterion
Scope limitation
Certificate number + expiry
Change-control trigger + last review
A blank field is not a pass. A supplier declaration is not a finished-product result. A method name is not a certification.
Exact wording, identified product and BOM, target market, competent evidence, report scope, sample state, result, limitations, and responsible reviewer.
Methods vary by property. FTC substantiation, EPA/FIFRA, FDA intended-use, CPSC, state, and market rules may also control whether wording is permissible.
A test method describes an evaluation. It does not establish that an unspecified product passes or that a laboratory result produces a health or field-use outcome.